Zhende Medical released its 2026 interim report, with total operating revenue of 2.224 billion yuan and net profit attributable to the parent company of 144 million yuan. Net cash inflow from operating activities was 44.8976 million yuan, down 72.06% from the same period last year. The company's asset-liability ratio was 28.78%, gross margin was 34.59%, ROE was 2.53%, and diluted earnings per share was 0.54 yuan. The number of shareholders was 8,152, and the top ten shareholders held 68.46% of the total share capital.
Zhende Medical Co LtdInterim report shows net profit of 144 million yuan, but operating cash flow down 72.06%.
